MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Anxiety"

  • MDS Virtual Congress 2021

    Changes in brain functional connectivity after cognitive behavioral therapy for anxiety in Parkinson’s disease: a longitudinal MRI study.

    G. Carey, R. Lopes, A. Moonen, K. Dujardin, A. Leentjens (Lille, France)

    Objective: To identify changes in brain functional connectivity (FC) after Cognitive Behavioral Therapy (CBT) for anxiety in patients with Parkinson’s disease (PD). Background: Recently we…
  • MDS Virtual Congress 2021

    Anxiety and depression in patients with Parkinson’s disease selected for magnetic resonance-guided focused ultrasound thalamotomy.

    O. Kachemaeva, R. Galimova, D. Krekotin, Y. Sidorova, I. Buzaev, A. Saveliev, N. Mukhamadeeva, G. Akhmadeeva (Ufa, Russian Federation)

    Objective: To assess the severity of anxiety and depression in patients selected for treatment with the magnetic resonance-guided focused ultrasound thalamotomy (MRgFUS TT) before the…
  • MDS Virtual Congress 2021

    THE ASSOCIATION OF ANXIETY AND DEPRESSION WITH TREMORS IN PARKINSON’S DISEASE PATIENTS

    F. Susanti, C. Arina, H. Hutagalung (Medan, Indonesia)

    Objective: To determine the relation between anxiety and depression with tremors in patients with PD so that it can be possible to detect the symptoms…
  • MDS Virtual Congress 2021

    Effect of COVID-19 stressors on mental health and quality of life in Parkinson’s disease

    L. Dommershuijsen, A. Heide, E. Berg, J. Labrecque, M K. Ikram, M A. Ikram, B. Bloem, R. Helmich, S. Darweesh (Nijmegen, Netherlands)

    Objective: To investigate subgroup differences in the effect of COVID-19 stressors on mental health and quality of life in people with Parkinson’s disease. Background: In…
  • MDS Virtual Congress 2021

    The fear of progression of Parkinson’s Disease

    S. Mayer, E. Tekampe, A. Frank, T. Feige, H. Reichmann, B. Falkenburger (Dresden, Germany)

    Objective: Determine fear of progression (FoP) and its influencing factors in Parkinson's disease (PD) patients to alleviate the psychosocial distress it induces. Background: PD patients…
  • MDS Virtual Congress 2021

    Are we addressing the emotional burden? – recognition of mood disorders in patients with essential tremor

    G. Douglas, A. Doyle, S. Rafee, S. O'Riordan (Dublin, Ireland)

    Objective: To examine the assessment of non-motor symptoms in essential tremor in movement disorder clinics. Background: Essential tremor (ET) is one of the most common…
  • MDS Virtual Congress 2021

    Nurse-led rapid access mental health clinic: a new care pathway in Parkinson’s disease

    S. Lidstone, K. Marcelle (Toronto, Canada)

    Objective: To provide rapid evaluation and non-pharmacological treatment of mental health symptoms in Parkinson's disease (PD) patients and their caregivers. Background: Mental health problems are…
  • MDS Virtual Congress 2021

    Acute functional movement disorder in a Lupus patient

    D. Rebolledo, J. Diestel, I. Reyes (Mexico City, Mexico)

    Objective: Movement disorders (MD) in autoimmune diseases are uncommon. However, the initial presentation required that the clinicians characterize the clinical phenomenology. Rheumatological patients' complexity required…
  • MDS Virtual Congress 2021

    Analysis of the correlation between the raphe nucleus echo and neurological diseases with depression/anxiety.

    YAN. Shao, YI. Liu (Dalian, China)

    Objective: The objective of this study is to assess raphe nucleus echo whether can be used as a means to distinguish endogenous and reactive depression/anxiety, so as to…
  • MDS Virtual Congress 2020

    Frequency of Wearing-Off Symptoms in Parkinson’s disease Fluctuators: An on/off evaluation

    K. Perepezko, J. Hinkle, K. Mills, G. Pontone (Baltimore, MD, USA)

    Objective: To determine if the frequency of wearing-off symptoms in Parkinson’s disease (PD) patients who report fluctuations differs from patients without fluctuations. Background: Wearing-off, the…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 17
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25676 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley